Sangamo Biosciences reported $-48436000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amgen AMGN:US $ 2378M 1550M
Avrobio Inc AVRO:US -32620000 1.24M
Bayer BAYN:GR 530M 2.81B
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Gilead Sciences GILD:US $ 3842M 1596M
GlaxoSmithKline GSK:LN 1.94B 263M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
Johnson & Johnson JNJ:US $ 3849M 2813M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Merk MRK:US $ 4826M 3212M
Novartis NOVN:VX 3.23B 246M
Omeros OMER:US $ -18253000 5.76M
Pfizer PFE:US $ 7647M 1733M
Regulus Therapeutics RGLS:US $ -8.42M 1.78M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M
Ziopharm Oncology ZIOP:US $ -22296000 343K